Alan B. Lancz & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Alan B. Lancz & Associates's LLY Position: Q3 2026 in Review
Alan B. Lancz & Associates held its Eli Lilly (LLY) position steady in Q3 2026 at 1,415 shares worth $1.64M. The position accounts for 1.87% of the portfolio, ranked #13.
Alan B. Lancz & Associates first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.7M in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Alan B. Lancz & Associates held 1,415 shares of Eli Lilly worth $1.64M as of Q3 2026.
- Alan B. Lancz & Associates left its Eli Lilly share count unchanged in Q3 2026.
- Eli Lilly made up 1.87% of Alan B. Lancz & Associates's portfolio in Q3 2026, its #13 holding.
- Alan B. Lancz & Associates first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- Alan B. Lancz & Associates's Eli Lilly position peaked at $1.7M in Q2 2026.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Alan B. Lancz & Associates's 13F filing for Q3 2026, filed 10 Nov 2026.